Literature DB >> 18201068

Contributions of the carboxyl-terminal helical segment to the self-association and lipoprotein preferences of human apolipoprotein E3 and E4 isoforms.

Takaaki Sakamoto1, Masafumi Tanaka, Charulatha Vedhachalam, Margaret Nickel, David Nguyen, Padmaja Dhanasekaran, Michael C Phillips, Sissel Lund-Katz, Hiroyuki Saito.   

Abstract

To understand the molecular basis for the different self-association and lipoprotein preferences of apolipoprotein (apo) E isoforms, we compared the effects of progressive truncation of the C-terminal domain in human apoE3 and apoE4 on their lipid-free structure and lipid binding properties. A VLDL/HDL distribution assay demonstrated that apoE3 binds much better than apoE4 to HDL 3, whereas both isoforms bind similarly to VLDL. Removal of the C-terminal helical regions spanning residues 273-299 weakened the ability of both isoforms to bind to lipoproteins; this led to the elimination of the isoform lipoprotein preference, indicating that the C-terminal helices mediate the lipoprotein selectivity of apoE3 and apoE4 isoforms. Gel filtration chromatography experiments demonstrated that the monomer-tetramer distribution is different for the two isoforms with apoE4 being more monomeric than apoE3 and that removal of the C-terminal helices favors the monomeric state in both isoforms. Consistent with this, fluorescence measurements of Trp-264 in single-Trp mutants revealed that the C-terminal domain in apoE4 is less organized and more exposed to the aqueous environment than in apoE3. In addition, the solubilization of dimyristoylphosphatidylcholine multilamellar vesicles is more rapid with apoE4 than with apoE3; removal of the C-terminal helices significantly affected solubilization rates with both isoforms. Taken together, these results indicate that the C-terminal domain is organized differently in apoE3 and apoE4 so that apoE4 self-associates less and binds less than apoE3 to HDL surfaces; these alterations may lead to the pathological sequelae for cardiovascular and neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18201068      PMCID: PMC2692928          DOI: 10.1021/bi701923h

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  52 in total

Review 1.  Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond.

Authors:  R W Mahley; Y Huang
Journal:  Curr Opin Lipidol       Date:  1999-06       Impact factor: 4.776

2.  Apolipoprotein E and atherosclerosis: beyond lipid effect.

Authors:  Jean Davignon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-02       Impact factor: 8.311

3.  Self-association of human apolipoprotein E3 and E4 in the presence and absence of phospholipid.

Authors:  M A Perugini; P Schuck; G J Howlett
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

4.  Lipid association-induced N- and C-terminal domain reorganization in human apolipoprotein E3.

Authors:  V Narayanaswami; S S Szeto; R O Ryan
Journal:  J Biol Chem       Date:  2001-08-01       Impact factor: 5.157

5.  Lipid binding-induced conformational change in human apolipoprotein E. Evidence for two lipid-bound states on spherical particles.

Authors:  H Saito; P Dhanasekaran; F Baldwin; K H Weisgraber; S Lund-Katz; M C Phillips
Journal:  J Biol Chem       Date:  2001-08-30       Impact factor: 5.157

6.  Examination of lipid-bound conformation of apolipoprotein E4 by pyrene excimer fluorescence.

Authors:  Jessica Drury; Vasanthy Narayanaswami
Journal:  J Biol Chem       Date:  2005-02-11       Impact factor: 5.157

Review 7.  Apolipoprotein E: far more than a lipid transport protein.

Authors:  R W Mahley; S C Rall
Journal:  Annu Rev Genomics Hum Genet       Date:  2000       Impact factor: 8.929

8.  Generation of a recombinant apolipoprotein E variant with improved biological functions: hydrophobic residues (LEU-261, TRP-264, PHE-265, LEU-268, VAL-269) of apoE can account for the apoE-induced hypertriglyceridemia.

Authors:  Kyriakos E Kypreos; Ko W van Dijk; Louis M Havekes; Vassilis I Zannis
Journal:  J Biol Chem       Date:  2004-12-02       Impact factor: 5.157

9.  Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice.

Authors:  Faith M Harris; Walter J Brecht; Qin Xu; Ina Tesseur; Lisa Kekonius; Tony Wyss-Coray; Jo Dee Fish; Eliezer Masliah; Paul C Hopkins; Kimberly Scearce-Levie; Karl H Weisgraber; Lennart Mucke; Robert W Mahley; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-25       Impact factor: 11.205

10.  Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism.

Authors:  Prathima Acharya; Mark L Segall; Mohamed Zaiou; Julie Morrow; Karl H Weisgraber; Michael C Phillips; Sissel Lund-Katz; Julian Snow
Journal:  Biochim Biophys Acta       Date:  2002-09-05
View more
  32 in total

1.  Fluorescence analysis of the lipid binding-induced conformational change of apolipoprotein E4.

Authors:  Chiharu Mizuguchi; Mami Hata; Padmaja Dhanasekaran; Margaret Nickel; Michael C Phillips; Sissel Lund-Katz; Hiroyuki Saito
Journal:  Biochemistry       Date:  2012-07-03       Impact factor: 3.162

2.  Impact of self-association on function of apolipoprotein A-I.

Authors:  Shobini Jayaraman; Sumiko Abe-Dohmae; Shinji Yokoyama; Giorgio Cavigiolio
Journal:  J Biol Chem       Date:  2011-08-11       Impact factor: 5.157

3.  The extent of pyrene excimer fluorescence emission is a reflector of distance and flexibility: analysis of the segment linking the LDL receptor-binding and tetramerization domains of apolipoprotein E3.

Authors:  Gursharan K Bains; Sea H Kim; Eric J Sorin; Vasanthy Narayanaswami
Journal:  Biochemistry       Date:  2012-07-26       Impact factor: 3.162

4.  Conformational analysis of apolipoprotein E3/E4 heteromerization.

Authors:  Kai-Han Tu; Devan Abhari; Vasanthy Narayanaswami
Journal:  FEBS J       Date:  2019-03-13       Impact factor: 5.542

5.  Biophysical analysis of progressive C-terminal truncations of human apolipoprotein E4: insights into secondary structure and unfolding properties.

Authors:  Angeliki Chroni; Serapion Pyrpassopoulos; Angelos Thanassoulas; George Nounesis; Vassilis I Zannis; Efstratios Stratikos
Journal:  Biochemistry       Date:  2008-08-09       Impact factor: 3.162

6.  The roles of C-terminal helices of human apolipoprotein A-I in formation of high-density lipoprotein particles.

Authors:  Kohjiro Nagao; Mami Hata; Kento Tanaka; Yuki Takechi; David Nguyen; Padmaja Dhanasekaran; Sissel Lund-Katz; Michael C Phillips; Hiroyuki Saito
Journal:  Biochim Biophys Acta       Date:  2013-10-09

7.  O-glycosylation on cerebrospinal fluid and plasma apolipoprotein E differs in the lipid-binding domain.

Authors:  Sarah A Flowers; Oliver C Grant; Robert J Woods; G William Rebeck
Journal:  Glycobiology       Date:  2020-01-28       Impact factor: 4.313

8.  Interaction between the N- and C-terminal domains modulates the stability and lipid binding of apolipoprotein A-I.

Authors:  Mao Koyama; Masafumi Tanaka; Padmaja Dhanasekaran; Sissel Lund-Katz; Michael C Phillips; Hiroyuki Saito
Journal:  Biochemistry       Date:  2009-03-24       Impact factor: 3.162

9.  Biophysical properties of apolipoprotein E4 variants: implications in molecular mechanisms of correction of hypertriglyceridemia.

Authors:  Irina N Gorshkova; Kyriakos E Kypreos; Donald L Gantz; Vassilis I Zannis; David Atkinson
Journal:  Biochemistry       Date:  2008-11-25       Impact factor: 3.162

10.  Structural differences between apolipoprotein E3 and E4 as measured by (19)F NMR.

Authors:  Kanchan Garai; Sourajit M Mustafi; Berevan Baban; Carl Frieden
Journal:  Protein Sci       Date:  2010-01       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.